Lenox Wealth Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$7K Buy
202
+29
+17% +$992 ﹤0.01% 530
2021
Q4
$5K Hold
173
﹤0.01% 608
2021
Q3
$6K Sell
173
-19
-10% -$608 ﹤0.01% 534
2021
Q2
$6K Buy
+192
New +$6.32K ﹤0.01% 529

Other funds holding OGN

Lenox Wealth Advisors's OGN Position: Q1 2022 in Review

Lenox Wealth Advisors increased its Organon & Co (OGN) stake by 17% in Q1 2022, buying an estimated $992 and bringing the position to 202 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #530.

Lenox Wealth Advisors first reported a position in OGN in Q2 2021 and has held it in 4 quarters since. 819 funds tracked by Wall St. Rank hold OGN as of Q1 2022.

  • Lenox Wealth Advisors held 202 shares of Organon & Co worth $7K as of Q1 2022.
  • Lenox Wealth Advisors bought 29 Organon & Co shares in Q1 2022, an estimated $992.
  • Organon & Co made up ﹤0.01% of Lenox Wealth Advisors's portfolio in Q1 2022, its #530 holding.
  • Lenox Wealth Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 4 quarters since.
  • 819 funds tracked by Wall St. Rank held Organon & Co as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.